"White House Announces First 10 Medicare Drugs for Negotiations, Industry Awaits Impact"
The Biden administration is expected to announce the first 10 prescription drugs selected for Medicare price negotiations, marking a significant step in efforts to lower drug prices through direct negotiations between Medicare and pharmaceutical manufacturers. The announcement is scheduled to be made early next week, ahead of a White House event on Tuesday. The drugs on the list are expected to include blood thinners, diabetes medicines, and cancer drugs, which cost Medicare billions of dollars annually. The Biden administration aims to demonstrate its commitment to reducing drug prices, although the negotiated prices won't take effect until 2026. The administration faces legal challenges from drug companies and the U.S. Chamber of Commerce, but it remains determined to fight for lower drug prices.